HighTower Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

HighTower Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,948	Closed	-$243K	–	3828
2026 Q1	$243K	Sell	16,948 -9,203	-35%	-$137K	﹤0.01%	3333
2025 Q4	$394K	Buy	+26,151	New	+$393K	﹤0.01%	2820
2024 Q1	–	Sell	-69,907	Closed	-$1.02M	–	3645
2023 Q4	$1.02M	Buy	+69,907	New	+$976K	﹤0.01%	1829
2023 Q1	–	Sell	-74,681	Closed	-$1.16M	–	3425
2022 Q4	$1.16M	Buy	+74,681	New	+$1.16M	﹤0.01%	1596
2021 Q4	–	Sell	-14,278	Closed	-$385K	–	3307
2021 Q3	$385K	Buy	14,278 +1,880	+15%	+$53.8K	﹤0.01%	2249
2021 Q2	$358K	Buy	+12,398	New	+$343K	﹤0.01%	2248

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

HighTower Advisors's BMEZ Position: Q2 2026 in Review

HighTower Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2026, closing a stake of 16,948 shares — an estimated $243K sold.

HighTower Advisors first reported a position in BMEZ in Q2 2021 and held it in 6 quarters. The position peaked at $1.16M in Q4 2022. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

HighTower Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q2 2026 after selling out during the quarter.
HighTower Advisors sold 16,948 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $243K.
HighTower Advisors first reported a position in BlackRock Health Sciences Trust II in Q2 2021 and held it in 6 quarters.
HighTower Advisors's BlackRock Health Sciences Trust II position peaked at $1.16M in Q4 2022.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.